Drugs / Mountain Cedar pollen allergenic extract
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03682965 | Sep 2018 → Mar 2019 | conjunctivitis, seasonal allergic rhinitis | Christopher Thompson, MD | Completed | Met primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Mountain Cedar pollen allergenic extract | “Mountain Cedar pollen allergenic extract is an FDA-approved, commercially available product for diagnosis and hypo-sensitization treatment of allergies.” NCT03682965 ↗ |